Gail Boudreaux, Director, President and CEO, on July 17, 2026, executed a purchase for 2,725 shares in Elevance Health (ELV) for $1,002,230. Following the Form 4 filing with the SEC, Boudreaux has control over a total of 172,036 common shares of the company, with 171,976 shares held directly and 60 controlled indirectly.
SEC Filing:
Price: $369.48, Change: $-3.37, Percent Change: -0.90%